Form 4: ANI Pharmaceuticals SVP, Generics, Ori Gutwerg, Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, disposed of 1,570 shares of common stock to cover tax obligations related to vesting restricted stock.
Summary
- On February 28, 2025, Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, disposed of 1,570 shares of common stock.
- The shares were withheld for tax purposes in connection with the vesting of 4,342 shares of restricted stock.
- The transaction was exempt under Rule 16(b)-3.
- The price per share was $61.89.
- Following the transaction, Gutwerg directly owns 99,176 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a standard tax-related stock disposal, which is a common occurrence when restricted stock vests.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of transaction: Disposal of 1,570 shares of common stock. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.